Abstract
The American Geriatrics Society’s (AGS) 2023 Beers Criteria identifies potentially inappropriate medications (PIMs) to use in geriatric patients defined as greater than or equal to 65 years of age. This population experiences pharmacokinetic and pharmacodynamic changes, which raise the risk of potentially harmful side effects. The Beers Criteria were developed as a clinical tool to help healthcare providers improve medication safety in this vulnerable population. The main focus of this article is on commonly seen medications and the rationale for recommended avoidance in geriatric patients. Additionally, a table of potentially clinically important drug-drug interactions that should be avoided in older adults is included.
Recommended Citation
Motilall H, Maberry K, Quinter C. A Review of Medications Listed in the 2023 Beers Criteria. Transformative Medicine. 2025; 4(2):32-37. doi: https://doi.org/10.54299/tmed/zwnc6661.